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ABSTRACT
Bambang Udji Djoko Rianto - Human papillomavirus (HPV) as the causal factor of tympanal cholesteatoma
in malignant-type chronic suppurative otitis media
Background: Tympanal cholesteatoma is an uncoordinated, uncontrolled hyperproliferative epidermic epithelial
cells keratinized with aggressive, erosive and destructive development to the mucous membrane and the
bone of external auditory canal and tympanic cavity. This process is invasive and may migrate to the
surrounding tissue. Ethiopathogenesis of tympanic cholesteatoma is unknown. Histological examination
shows that there are hyperproliferative development, papillomatous, koilocyte clusters and destruction of
the bone. These abnormalities are characteristics of papillomavirus.
Objective: To know the whether HPV-18 is the risk factor in the occurrence of tympanic cholesteatoma ini
malignant-type chronic suupurative otitis media.
Methods: A case-control study was conducted on 31 tympanal cholesteatoma specimens from malignant-
type chronic suppurative otitis media as the case group, and 31 mucosal tympanic cavity specimens from
benign-type chronic suppurative otitis media as the control group. For detecting Polymerase chain reaction
(PCR) examination was used to detect DNA HPV-18, that performed in Parasitology Laboratorium Faculty
of Medicine, Gadjah Mada University.
Results:  Polymerase chain reaction (PCR) examination showed that there were 21 (67.7%) DNA HPV-18
positive specimens in the case group, while in the control group there were 5 (16.1%) DNA HPV-18
positive specimens. This difference was statistically significant (p= 0.0001; Odds ratio:10.92; 95%
confidence interval = 2.83-45.29). Immunohistochemistry examination was used to identify host immune
response to HPV, by observing the interleukin-1 (IL-1) and interferon g (IFN g) expressions. Both IL-1 and
IFN g cytokines were highly expressed in tympanic cholesteatoma samples, compared to both in the
control group. The difference was statistically significant (p< 0.05, Odds ratio 14.29; 95% confidence
interval: 3.64-60.5 and p< 0.05, Odds ratio:10.2; 95% confidence interval: 2.74-40.35, respectively).
Conclusion: It can be concluded that HPV-18 DNA was iidentified, and was one of the multiple risk factors
in the occurence of tympanic cholesteatoma in malignant-type chronic suppurative otitis media..
Key words: tympanal cholesteatoma - human papillomavirus - malignant-type chronic suppurative otitis
media
ABSTRAK
Bambang Udji Djoko Rianto  Human papillomavirus (HPV) sebagai faktor penyebab kolesteatoma timpani
pada otitis media suppurativa kronik tipe maligna
Latar Belakang: Kholesteatoma timpani merupakan hiperproliferasi sel epitel keratin kavitas timpani yang
tidak terkoordinasi dan tidak terkendali, tumbuh secara agresif, erosif, dan destruktif terhadap mukosa dan
tulang (kanalis auditorius eksternus, kavitas timpani). Pertumbuhan hiperproliferatif sel-sel tersebut mengalami
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diferensiasi dengan manifestasi klinis berupa invasi dan migrasi ke jaringan sekitarnya. Etiopatogenesis
kholesteatoma timpani hingga saat ini masih belum dapat diketahui secara pasti. Gambaran histologis
menunjukkan adanya pertumbuhan sel epitel skuamus kompleks yang hiperproliferatif, papillomatosus dan
klaster koilosit yang agresif, disertai destruksi tulang, sehingga besar kemungkinan melibatkan peran virus
papilloma.
Tujuan: membuktikan bahwa HPV-18 merupakan faktor risiko kejadian kolesteatoma timpani pada otitis
media suppurativa kronis tipe maligna.
Metode: Penelitian ini menggunakan desain kasus kontrol terhadap 31 spesimen kelompok kasus otitis
media supuratif kronik maligna (kholesteatoma +), sedangkan kelompok kontrol adalah 31 spesimen otitis
media supuratif kronik benigna (kholesteatoma -). Pemeriksaan polymerase chain reaction (PCR) digunakan
untuk mendeteksi DNA HPV-18 yang dilakukan di Laboratorium Parasitologi Fakultas Kedokteran, Universitas
Gadjah Mada.
Hasil: Berdasarkan pemeriksaan menggunakan polymerase chain reaction (PCR) untuk mengidentifikasi
adanya DNA HPV, didapatkan 21 (67,7%) sampel positif DNA HPV-18 pada kelompok kasus, sedangkan
pada kelompok kontrol sebanyak 5 (16,1%) sampel positif DNA HPV-18.  Berdasarkan analisis statistik tes
Chi square, perbedaan jumlah sampel DNA HPV-18 tersebut beda bermakna (p= 0,0001). Rasio Odds:
10,92 (interval kepercayaan 95%= 2,83-45,29). Identifikasi respon imun inang terhadap HPV berupa
ekspresi sitokin yaitu: interleukin-1 (IL-1) dan interferon g (IFN g) menggunakan metode pemeriksaan
imunohistokimiawi menunjukkan bahwa ekspresi sitokin IL-1 dan IFN g pada kelompok sampel kholesteatoma
timpani lebih tinggi secara bermakna dibanding kelompok kontrol ((p< 0,05, rasio Odds14,29; interval
kepercayaan 95%: 3,64-60,5 untuk ekspresi IL-1, dan p< 0,05, rasio Odds:10,2; interval kepercayaan
95%: 2,74-40,35).
Simpulan: Hasil penelitian tersebut menyimpulkan bahwa terdapat DNA HPV-18 dalam kholesteatoma
timpani dan merupakan salah satu faktor risiko pada kejadian kholesteatoma timpani pada penderita otitis
media supuratif kronis tipe maligna.
INTRODUCTION
Tympanic cholesteatoma is an uncontrolled,
uncoordinated, and differentiated hyperproliferative
process of keratinized squamous epithelial cells with
aggressive and erosive growth, and destructs the
mucosal layer and bone of external auditory canal
and tympanic cavity. It can be followed by granulat-
ion tissue formation. These hyperproliferative cells
invade and migrate to surrounding tissues.1, 2
Malignant-type chronic suppurative otitis media
(MtCSOM) is a chronic inflammatory condition with
tympanic cholesteatoma formation. The number of
MtCSOM patient in Department of Ear, Nose and
Throat of Dr. Sardjito Hospital between 1998 and
1999 were 40 patients. Only 25 of 40 patients
underwent surgery procedure, and 3 of these patient
died. Deric et al. (1998) reported that 84%
MtCSOM were suffered from cerebral abscess
and 80% suffered from cerebellum abscess
complication, with mortality rate 18% and 29%,
respectively.3 Until now, surgery procedure is the
treatment of choice, without consideration of the
causal factor and ethiopathogenesis of  tympanic
cholesteatoma.4 The etiopathogenesis of tympanic
cavity is still debatable. Even though there were
theory about it, none are based on valid evidence.
Principally, these theories can be divided to two
periods: before and during biomolecular periods.
Habberman (1989) stated that tympanic
cholesteatoma was formed from epidermal epithe-
lial migration of tympanic membrane remnant or
external auditory canal through tympanic membrane
perforation, and then it entered the tympanic cavity.
This theory was supported by Palva, who suggested
that the epithelial migration would be increased by
certain conditions.5 Ruedi (1958) cit Sanna & Zini
(1982) stated that tympanic cholesteatoma was
developed from embryonal ectoderm remnant in
tympanic cavity after stimulated by certain conditions.
Atticks cholestea-toma type resulted from invagination
process of flaccid part of tympanic membrane (ex
vacuo theory).6 The other authors stated that
tympanic cavity epithelial layer was resulted from
the metaplasia of cuboid cells turned into squamous
complex type of tympanic cavity epithelial layer.7,8,9
Chesire et al. (1996) stated that tympanic
cholesteatoma was resulted from keratinized
epidermal cell layer of tympanic membrane and
external auditory canal skin migration through the
tympanic cavity, while Sudhoff et al. (1995) added
that the sub-epithelial tissue inflammation and
granulation tissue supported the migration theory
and osteolytic activation of tympanic choles-
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teastoma.10,11 Based on the research results, Broekaert
et al. (1982) showed that there was an overexpression
of cytokeratin in tympanic cavity mass, and was
the characteristic of hyperproliferative epithelial
cells.12
The hyperproliferative characteristic was
supported by the research by Bujia et al. (1993)
which showed that cytokeratin overexpression in
tympanic cavity was 3 times higher than that in
normal canal skin, and there were hyperproliferatve
and metaplasia cells.13
Histological aspect of tympanic cholesteatoma
showed the papillomatous and koilosit cluster,
aggressive growth, and bone destruction. These
feature was the same as the characteristic of
abnormality caused by papillomavirus. Bergmann
et al. (1994) and Stremlau et al. (1995) stated that
there was DNA of human-papilloma virus 11 (HPV
11) in the tympanic cholesteatoma mass, while Chao
et al. (2000) had identified the DNA of human-
papilloma virus 6 (HPV 6).14,15,16 Based on these
data, research questions were formulated: Can
HPV be detected in tympanic cholesteatoma in
MtCSOM patients, and is HPV one of multiple risk
factors in the etiopathogenesis of tympanic
cholesteatoma in MtCSOM patients? The aim of
this study was to determine the role of HPV in
etiopathogenesis of tympanic cholesteatoma in
MtCSOM patients by identifying the DNA, type of
HPV, and cytokine (IL-1 and IFNã) expression as
the host immune response against HPV using
Polymerase Chain Reaction (PCR) and immuno-
histochemistry examination.
Until recently, there was no studies discussing
the role of HPV and host immunity response in
tympanic cholesteatoma, using appropriate, valid and
reliable methodological research. Based on this fact,
these hypotesis were formulated: HPV DNA can
be identified in the tympanic cholesteatoma mass
of MtCSOM patients, and HPV is one of the
multiple risk factors in the occurrence of tympanic
cholesteatoma in MtCSOM patients.
The role of Human-papillomavirus (HPV)
The accumulation of keratin cell debris in
tympanic cavity showed that there is an increased
in keratin cell death process, that is stimulated by
keratin cell differentiation. This condition also
showed that it is related with the apoptosis in the
term of keratinized and cornification process, which
is is a part of essential cell differentiation process.17
This pathological feature is an appropriate condition
for HPV replication. The inflammation process in
tympanic cavity stimulates the HPV replication, and
the tympanic cholesteatoma growth will be
aggressive.15
Herber et al. (1996) stated that HPV is a small
DNA virus type that may infect every epithelial
tissue. HPV 16 and HPV 18 are the high risk HPV
type that related to the incidence of 90% cervix
carcinoma.18 The genome of HPV DNA is
integrated with the host chromosomes (Schwarz
et al., 1985; Yee et al., 1985), and the expression
of E6 and E7 viral genes.19,20 These genes is related
to the change of E6 and E7 mRNAs stability, and
the cell growth.21,22,23 The E6 and E7 play important
role in the cervix carcinoma development. Herber
et al (1996) stated that those proteins play role in
the hyperproliferative process in the carcinogenesis
and maintain the malignant condition.24
The life cycles of high and low risk HPV types
are related to the epithelial cells differentiation. The
multiplication of viral genes in the suprabasal layer
needs the protein to inhibit and exit from the normal
cell cycle during the differentiation state. This
process is controlled by protein pRb (protein
Retinoblastoma) and p53 (protein p53). The E7 of
low risk HPV changes the cell differentiation in
HPV-infected cell.25
The HPV 16 and HPV 18 play role in the
induction and the progressive hyperproliferative cell
growth. The E6 and E7 oncoproteins were identified
and had roles in the malignant cell growth in vitro.26
The HPV cell infection process was consisted of
the HPV particle absorption by cell in the basal
layer that suffered from local surface cell trauma,
followed by the expansion of HPV clone genome
as the extra chromosome element.27,28,29
The undifferentiated cells expanded by the
clone become non-productive cells, and do not result
in viral pro-gene, but still express the viral gene in
the low level. The E7 gene is one of the viral gene
expression. Finally, the infected cell will growth into
the terminal differentiation state in the superficial
layer. During this process, a group of infected cells
will be produced and resulted in viral pro-gene.
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Those HPV infected cells can be detected in the
superficial cell layer.18
Certain HPV type plays a role in the induction
of keratinized epithelial cells remnant proliferation
in the tympanic cavity. The increased cell
proliferation is needed for HPV replication. The
tympanic cholesteatoma cell growth induces and
stimulates the inflammation response in the tympa-
nic cavity. The cellular immunity infiltrates and
expresses certain cytokines, including the growth
factor. Furthermore, the interaction between epithe-
lial cells and cellular immune response product will
be occurred, causing apoptosis inhibition, abnormal
cell cycle regulation, and cell hyperproliferation.18
Host immune response to HPV infection
HPV is an intracellular parasite who needs
biochemical substance in the host for protein and
carbohydrate synthesis to maintain the viral life
cycle. There are DNA (for example, HPV) and
RNA virus type.30
The HPV infects the host cell by binding to the
specific receptor in cell host. The HPV particle (virion)
penetrates host cell without virion mantle, and then
liberates its nucleic acid, followed by transcription
process, and production of viral protein. The HPV
genome will be replicated, followed by virion
rearrangement, and it will be released and infects
surrounding cells. HPV has capability to infect, persist,
and initiate the manifestation in infected cells.21,30,32
The interaction between HPV and host immune
system is a very complex process which determines
the effect of infection and the strategy of prevention.
Qualitatively, HPV is an immunogen and pathogen
complex which induces cellular and humoral immune
response.32
The host infected by HPV produces interferon
(IFN) a and b which stimulate antiviral mechanisms
in the surrounding infected cells to prevent the
invading of infection. Cytokine IFN-g is expressed
to directly inhibit the viral replication, and increase
the efficiency of adaptive immune response by
increasing the class I and II Major Histocompati-
bility Complex (MHC), beside macrophages and
Natural killer (NK) cell activation.28,29,30
The defect in T cell function causes an increase
in HPV progressiveness, which related to the
incidence of cell hyperproliferation/cancer. The
cytolytic T lymphocyte (CTL) do not respond to E7
HPV 16 gene in cervix carcinoma patients, event if
there are humoral and CD4+ cell responses. Until now,
there was  no known exact mechanism of T cell
response.26
The microorganism infection in the tympanic
cavity mucosal layer worsens local inflammation,
and increases the cytokine expression. This condition
induces non- aggressive tympanic cholesteatoma
to become aggressive.33
METHODS
This case control study was conducted in ENT
Department, Faculty of Medicine, Gadjah Mada
University (GMU)/Dr. Sardjito Hospital Yogyakarta
during September 2001 until August 2004. The case
group sample was Malignant type Chronic Suppura-
tive Otitis Media (MtCSOM: positive tympanic
cholesteatoma), while the control group was Benign-
type Chronic Suppurative Otitis Media (BtCOM:
negative tympanic cholesteatoma).
Consecutive sampling was used to recruite and
obtain the samples. The inclusion criteria for case
group was patient suffered from MtCSOM, while
the control group was patient suffered from
BtCOM. Both groups underwent surgery
procedure. The exclussion criteria: patient was not
agree participated in this researh. Specimen that
was underwent PCR (Polymerase Crain Reaction):
cholesteatoma mass (case group), and mucous
tissue or granuloma (control group), from midle ear
that obtained during surgery.
The independent variables as risk factor were:
sex, site of ear, age, and HPV DNA, while the
dependent variable (outcome variable): cholesteatoma
mass. Measurement that was used were routine ENT,
PCR examination, and immunohistochemistry.
The PCR examination was used to identify HPV
DNA, conducted in Biological Science Laboratory
GMU and Parasitology Laboratory Faculty of
Medicine, GMU, while Immunohistochemistry
examination was used to identify the IL-1 and IFNg
expressions, conducted in the Anatomic Pathology
Laboratory Faculty of Medicine, GMU.
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RESULT AND DISCUSSION
Based on the sample size calculation formula
(a: 5%; b: 20%, 95% CI, and Odds ratio: 4), there
were 62 samples included in this study, consisted of
31 samples in case group and 31 samples in control
group. The age range of samples was 4 to 52 year
old, consisted of 11 (45.8%) male and 13 (54.2%)
female in the case group, 10 (41.7%) male and 14
(58.4%) female in the control group (TABLE 1).
Chi-square and Mantel-Haensel test showed
that both groups were not significantly different for
the each variable, or in other terms, both groups
were in the homogeneous condition.
TABLE 1. Characteristic of samples
HPV DNA detection
PCR and agar electrophoresis examinations
detected HPV DNA 18 in 21 (67%) samples in the
case group and 5 (16%) HPV DNA 18 positive
samples in the control group (TABLE 2). Statistical
analysis using Chi-square test revealed a significant
difference between case group and control group
(p=0.0001, Odds ratio 10.92, 95 % CI =2.8345.29).
TABLE 2. HPV DNA 18 in case group and control group
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1997). The study did not mention about the
differences between  latent, sub-clinical and clinical
period. Even though the HPV 16 and 68 were
usually be considered in high risk type, based on its
presentation in displasia lesion and oral cancer,
those HPV also could detected in normal oral cavity
with high frequency 51.3%.36 HPV 18 had a normal
keratinocyte transformation action in human and
showed carcinogenic effect in vitro.37,38 Based on
epidemiological studies on oral cancer patients, there
were other factors that influence the pathogenesis
of oral cavity carcinogenesis of the tumor. They
were cigarette smoking, tobacco chewing, alcohol,
old age, HIV infection, and sexual habit.39
HPV DNA detected in oral mucosa showed
that persistent or temporary HPV infection might
occur in human. Usually, HPV were transmitted
by sexual contacts or non-sexual means, for
example, by autoinoculation from a region to other
region in the same individual, or by vertical
transmission during perinatal period.40,41
Interleukin-1 (IL-1) identifications
Based on IHC examination, there was a
significant difference (p < 0.001; CI95%: 4.94 
14.23) in IL-1 expressions between positive DNA
HPV 18 case group (23.62 ± 6.9) and control group
(11.73 ± 8.24).
If all samples were classified into positive and
negative DNA HPV 18, there was no significant
difference (p: 0.275; CI95%: -3.1-10.3) in IL-1
expressions between positive DNA HPV 18 case
group (23.62 ± 6.9) and control group (20.0 ± 4.06),
as well as negative DNA HPV 18 negative case
group (8.4 ±3.9) and control group (11.73 ± 8.24)
(TABLE 3).
TABLE 3. IL-1 expressions in both groups
In case group of samples with complication,
the IL-1 expression (37 ± 4.63) was significant
statistically higher (p < 0.001; CI95%: 9.86  21.36)
than samples without complications (21.39 ± 4.38).
Bujia et al. (1996) studied 20 samples of
extract of tympanic cholesteatoma tissue using
bicinchonic acid protein assay and enzyme-linked
immunoabsorbent assay (ELISA).42 They found a
higher expression of IL 1a in tympanic
cholesteatoma compared to the normal auditory
canal skin, 34.9 ±19.5 ng/g and 6.7±2.8 ng/g,
respectively. Statistically, this result was significantly
different. (p < 0.001). In the skin samples, there
wa a higher concentration of IL-1 RA (248.3±30.2
ng/g) compared to that in the tympanic
cholesteatoma (80.8±13.5 ng/g), and statistically
they were significantly different (p < 0.01). IL-1
activity could not be detected in the skin samples.
Biologic activity of IL-1 was analyzed by the cell
line LBRM-33. It could be concluded that there
was an increase of IL-1 expression along with the
decrease of IL-1-RA. Furthermore, imbalance of
IL-1 RA production and total IL-1 production
caused IL-1 to take an active position. The presence
of network between cytokines, and between IL-1
and other interleukin or other cytokines suggest that
the network has an important role in the pathogenesis
of tympanic cholesteatoma Interleukin-1a (IL-1a)
has an important role by stimulating thef keratin
cell proliferation and inducing bone resorption.
Some authors stated that the presence of
microorganism infection in MtCSOM would
increase the progressiveness of tympanic chole-
steatoma In this study, the type of microorganism
of the samples were not detected, because of no
differences in microorganism types between
MtCSOM and BtCSOM in the previous studies, so
that the response immune of the host was not
significantly different.43,44
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Interferon g (IFN-g) identification
Based on IHC examination, there was a
significant difference (p < 0.,001; CI95%: 4.09 
12.42) in IFN-g expression between positive DNA
HPV 18 case group (22.14 ± 4.9) and control group
(13.88 ± 8.37).
If all samples were classified into positive and
negative DNA HPV 18, there was no significant
difference (p: 0.275; CI95%: -3.1-10.3) in IFN-g
expressions between positive DNA HPV 18 case
group (23.62 ± 6.9) and control group (20.0 ± 4.06),
as well as negative DNA HPV 18 negative case
group (8.4 ± 3.9) and control group (11.73 ± 8.24)
(TABLE 4).
TABLE 4. IFN-g expressions in both groups
MtCSOM (positive tympanic cholesteatoma)
was commonly followed by bone destruction that
cause a decrease in the hearing acuity, vestibular
disturbance and intracranial complications. This
inflammation was associated with the cytokine
production; IL-1b, TNF-a, and IFN-g. These
cytokines play an important role in the regulation
and activation of osteoclast, and in bone resorption
process. Many kinds of inflammatory cells, including
macrophages and neutrophiles; were found in
MtCSOM. Those cells would produce nitrous oxide
(NO) after exposed and activated by cytokines.
NO had an effect on osteoclast activation.45
CONCLUSION
Based on the research resuls it could be
concluded that the HPV 18 DNA were identified
in the tympanic cholesteatoma mass of MtCSOM
patients, and HPV 18 was one of the multiple risk
factors in the occurrence of tympanic chole-
steatoma in MtCSOM patients.
Experimental research in animal samples is
needed to determine and support the exact role of
HPV 18 and other risk factors on the occurrence
of tympanic cholesteatoma. The role of HPV as a
risk factor should be considered in the persistent
otitis media treated with conservative treatment.
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